Printed From BioPortfolio.com
Ascendis Pharma Reports Third Quarter 2018 Financial Results
11:40 EST 29 Nov 2018 | Investing News Network
Ascendis Pharma (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address significant unmet medical needs, today announced financial results for the quarter ended September 30, 2018 and released preliminary phase 1 data for TransCon CNP. As quoted in the press release: “To support our vision for sustainable growth, we are creating a diversified … Continued
The post Ascendis Pharma Reports Third Quarter 2018 Financial Results appeared first on Investing News Network.
Original Article: Ascendis Pharma Reports Third Quarter 2018 Financial Results
